Novel uses in unconventional areas such as neurodegenerative conditions, non-alcoholic steatohepatitis (NASH), and cardiovascular disease prevention may enhance the therapeutic potential of these medicines
For the UK, any NHS availability would then depend on a further review by NICE (the National Institute for Health and Care Excellence)
THC, CBD, Product Type, and Timing Should Be Discussed Separately Saying I use cannabis is not enough information
Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process. The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs
In the phase 3 trial that measured outcomes at 20 weeks, most participants were able to reach the full dose and lost weight as their dose was increased
On top of this, glutathione production drops significantly as we age, leading to an inevitable imbalance of too much toxic stress and inflammation and not enough antioxidants to counter it